About 55 million people live with dementia worldwide. New research into why brain cells die is enabling scientists to develop effective Alzheimer’s drugs. About 55 million people worldwide live with some form of dementia —...
The drug aducanumab could be approved in the US and EU soon. It effectively combats the amyloid beta plaques in the brain that are indicative of Alzheimer’s disease. But does it also slow down memory...
Piramal Healthcare Ltd [stockquote]PIRHEALTH[/stockquote] has acquired the molecular imaging development portfolio of Bayer Pharma AG. Its newly created subsidiary called Piramal Imaging SA has entered in to an agreement to acquire the worldwide rights to...
